Joseph Estabrook

498 total citations
8 papers, 143 citations indexed

About

Joseph Estabrook is a scholar working on Molecular Biology, Hematology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph Estabrook has authored 8 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph Estabrook's work include Acute Myeloid Leukemia Research (4 papers), RNA modifications and cancer (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Joseph Estabrook is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), RNA modifications and cancer (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Joseph Estabrook collaborates with scholars based in United States, United Kingdom and Netherlands. Joseph Estabrook's co-authors include Eric T. Wang, Hailey Olafson, J. David Brook, Christopher B. Burge, Katy Eichinger, Kirti Bhatt, Amanda J. Ward, Daniel J. Treacy, Adam J. Struck and Thomas A. Cooper and has published in prestigious journals such as Blood, Human Molecular Genetics and Leukemia.

In The Last Decade

Joseph Estabrook

7 papers receiving 143 citations

Peers

Joseph Estabrook

MB

CMN

CCM

CR

NEURO

Linda Inuabasi United Kingdom

Hailey Olafson United States

Jamie Margolis United States

Mojgan Reza United Kingdom

Martin Jacko United States

Samineh Deheshi Canada

Rebecca Meyer‐Schuman United States

Benjamin Brinon France

Shay Fabbro United States

Ariadna Bargiela Spain

Linda Inuabasi United Kingdom

Joseph Estabrook

128 ×1.0

MB

100 ×1.2

CMN

17 ×1.1

CCM

4 ×0.3

CR

40 ×3.3

NEURO

Citations per year, relative to Joseph Estabrook Joseph Estabrook (= 1×) peers Linda Inuabasi

Countries citing papers authored by Joseph Estabrook

Since Specialization

Citations

This map shows the geographic impact of Joseph Estabrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Estabrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Estabrook more than expected).

Fields of papers citing papers by Joseph Estabrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Estabrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Estabrook. The network helps show where Joseph Estabrook may publish in the future.

Co-authorship network of co-authors of Joseph Estabrook

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Estabrook. A scholar is included among the top collaborators of Joseph Estabrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Estabrook. Joseph Estabrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Estabrook, Joseph, Julia Somers, Olga Nikolova, et al.. (2024). Predicting transcription factor activity using prior biological information. iScience. 27(3). 109124–109124. 1 indexed citations

2.

Coleman, Daniel J., Joseph Estabrook, Emek Demir, et al.. (2023). Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular Cancer Research. 21(7). 631–647. 5 indexed citations

3.

Rames, Matthew J., Joseph Estabrook, Josiah T. Wagner, et al.. (2023). Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles. Communications Biology. 6(1). 885–885. 11 indexed citations

4.

Braun, Theodore P., Joseph Estabrook, Cody Coblentz, et al.. (2022). Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia. 37(2). 478–487.

5.

Tsuchiya, Mitsuhiro, Yiu Huen Tsang, Wesley Horton, et al.. (2022). PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia. Leukemia. 36(7). 1781–1793. 8 indexed citations

6.

Braun, Theodore P., et al.. (2020). Oncogenic SETBP1 Mutations Combine with Activating Mutations in CSF3R to Produce a Highly Proliferative, Lethal Leukemia through Aberrant Myc Signaling. Blood. 136(Supplement 1). 51–52. 1 indexed citations

7.

Wang, Eric T., Daniel J. Treacy, Katy Eichinger, et al.. (2018). Transcriptome alterations in myotonic dystrophy skeletal muscle and heart. Human Molecular Genetics. 28(8). 1312–1321. 91 indexed citations

8.

Heeringen, Simon J. van, et al.. (2017). Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat. RNA Biology. 14(10). 1374–1388. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact